BBMPY yields 9.10% · PFE yields 6.13%● Live data
📍 BBMPY pulled ahead of the other in Year 1
Combined, BBMPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BBMPY + PFE for your $10,000?
BBMG Corporation, an investment holding company, engages in manufacturing and sale of cement and building materials in Asia, Europe, Africa, and internationally. The company's Cement and Ready-Mixed Concrete segment manufactures and sells cement and concrete. Its Modern Building Materials and Commerce and Logistics segment produces furniture and woods, decorative and fitting materials, and wall body and insulation materials; and offers commerce and logistics services. The company's Property Development segment develops and sells housing properties. Its Property Investment and Management segment invests in properties; and provides management and security services to residential and commercial properties. The company offers mortars and crushed stones, slag fine powders, coatings and construction hardware, glass made spectacle lenses, glass wool products, wood based panels, resins, building materials, limestone and cement clinkers, refractory materials and ceramics, aerated concrete products, machinery equipment and accessories, wind power equipment, doors and windows, and sanitary ceramics; wholesales coal, building and metal materials, and metal and metallic minerals; and imports and exports bulk commodities. It provides project and furniture decoration, construction contracting and project management, accommodation and conference, hotel management, finance leasing, property consultancy, property rental, technology development, goods transportation and storage, waste disposal, finance and financing advisory, exhibition, tourism, and knitting processing services; offers loading, offloading, and handling services; provides building material testing services; and operates sports projects, as well as publishes concrete world magazine, and provides advertising design and production services. The company was founded in 2005 and is headquartered in Beijing, the People's Republic of China.
Full BBMPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.